United States Pharmacopeia
Chair of Expert Committee on Packing,
Storing & Distribution of Drug Products
Mary is responsible for revision,
creation, and/or rescinding current
USP General Chapters. Installed
international team including
regulators, academia, industry and
consultants. Five year committement
of volunteerism to create standards
for the pharma/bio industry.
USP Update for Transportation & Distribution
Practices for Biotech & Clinical Supply Products
8
Senior GMP Inspector
Ian is Manager of the UK Defective
Medicines Report Centre for the MHRA
(UK Regulatory Agency) located in London.
The centre liaises with manufacturers,
distributors, hospitals and pharmacies to
direct recalls, issue timely notifications and oversee corrective
actions for confirmed and suspected medicine defects. Scope of the
work includes authorized medicines, unlicensed medicines and
IMPs. He is a registered Pharmacist and has postgraduate
qualifications in Pharmacology and Business Studies. He first
worked for the MHRA as a site inspector for Good Manufacturing
Practice and Good Distribution Practice at sites in the UK and
worldwide.
At the Summit >
At the Summit >
9:45 AM – Thursday, February 27
MHRA
th
Keynote: EU GDP Updates
New guideline on GDP of medicinal products for human use
9:00 AM – Thursday, February 27th